| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Anti-coronavirus spike; Anti-cov spike; Anti-ncov RBD; Anti-ncov S1;Anti-ncov spike; Anti-novel coronavirus RBD; Anti-novel coronavirus S1; Anti-novel coronavirus spike; Anti-RBD; Anti-S1; Anti-Spike RBD; E2; E2 glycoprotein; Human coronavirus spike glycoprotein; S; SARS-CoV-2 S1 RBD; S glycoprotein; Spike glycoprotein |
| Clonality | |
| Conjugate | |
| Form | Liquid |
| Host | |
| Immunogen | Recombinant Human Novel Coronavirus Spike glycoprotein(S) (319-541aa) (CSB-YP3324GMY1 and CSB-MP3324GMY1b1) |
| Isotype | |
| Product Type | |
| Reactivity | |
| Source | This product is a recombinant monoclonal antibody (VHH fused with human IgG1 Fc) expressed in HEK293F cells. |
| Storage | |
| Target | |
| UniProt # |
Overview
This is a monoclonal anti-S antibody raised in Human, conjugated with Biotin, with confirmed utility in ELISA. It is designed to detect S protein in Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV) and supports researchers working in microbiology contexts.
Key elements and design rationale
- Immunogen: Recombinant Human Novel Coronavirus Spike glycoprotein(S) (319-541aa) (CSB-YP3324GMY1 and CSB-MP3324GMY1b1) — determines the epitope region; confirm compatibility with sample preparation and expected post-translational modifications.
- Host species (Human): Requires anti-human-IgG secondary reagents for indirect detection.
- Monoclonal format: Single-epitope binding provides high specificity and lot-to-lot reproducibility. Confirm epitope accessibility under your assay conditions.
- Isotype (VHH-Fc): Matched secondary antibodies and isotype controls required. Compatible with standard Protein A/G purification workflows.
- Purification (Affinity chromatography): Enriches for specific immunoglobulin classes; reduces non-specific background vs. crude antisera.
- Biotin conjugate: Amplified detection via streptavidin/avidin reporters. Block endogenous biotin in biotin-rich tissue samples.
Biological background
S (also referred to as Anti-coronavirus spike, Anti-cov spike, Anti-ncov RBD, Anti-ncov S1,Anti-ncov spike, Anti-novel coronavirus RBD, Anti-novel coronavirus S1, Anti-novel coronavirus spike, Anti-RBD, Anti-S1, Anti-Spike RBD, E2, E2 glycoprotein, Human coronavirus spike glycoprotein, S, SARS-CoV-2 S1 RBD, S glycoprotein, Spike glycoprotein) is a protein target studied in Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV) systems. Expression, subcellular localization, and post-translational modifications vary across cell types and disease states — factors critical to antibody-based detection design. Consult UniProt, NCBI Gene, and primary literature for current annotation of S biology in microbiology.
Common research applications
- ELISA: Quantification of soluble target in biological fluids or culture supernatants. Ensure samples are within the linear detection range.
Notes for experimental interpretation
- Isotype controls: Use an isotype-matched (VHH-Fc from Human) control at equivalent concentration to assess non-specific background.
- Cross-reactivity: Confirm the clone does not cross-react with related family members under your assay conditions.
- Matrix effects: Sample matrix can affect performance; pilot dilution linearity and spike-recovery experiments are advised for quantitative studies.
- Species reactivity: Confirmed for Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV). Extrapolation to untested species requires empirical validation.
This product is a recombinant monoclonal antibody (VHH fused with human IgG1 Fc) expressed in HEK293F cells.
S is a protein target in Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV) biology. This monoclonal antibody raised in Human is designed to detect S in ELISA applications, with VHH-Fc isotype.
Reported reactive against Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV). Immunogen derived from Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV). Cross-reactivity with other species should not be assumed without documented data or empirical testing.
Reported for ELISA. Each format requires independent dilution optimization and appropriate controls. Unlisted applications require empirical testing.
Biotin enables streptavidin/avidin-amplified detection. Block endogenous biotin in biotin-rich tissues.
(1) Isotype control — VHH-Fc from Human at matching concentration; (2) Positive control — known S-expressing cell/tissue; (3) Negative control — knockdown/knockout sample for specificity; (4) Dilution linearity — verify proportional signal decrease in your matrix.
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
